Giant Biogene Holding Co., Ltd. (HKG: 2367)
Hong Kong
· Delayed Price · Currency is HKD 52.45
+1.60 (3.15%)
Oct 10, 2024, 9:33 AM HKT
Giant Biogene Holding Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 1,768 | 1,452 | 1,002 | 828.13 | 826.45 | 552.26 |
| Depreciation & Amortization | 37.67 | 33.69 | 27.24 | 23.94 | 22.14 | 17.85 |
| Other Amortization | 0.48 | 0.48 | 0.39 | 0.27 | 0.15 | 0.03 |
| Loss (Gain) From Sale of Assets | 0.51 | 2.88 | 2.91 | 0.18 | 0.23 | 0.01 |
| Loss (Gain) From Sale of Investments | -34.49 | -29.33 | 8.28 | -14.47 | -154.78 | -0.16 |
| Stock-Based Compensation | 56.98 | 20.52 | 17.66 | 16.49 | 0.59 | - |
| Provision & Write-off of Bad Debts | 0.79 | -0.03 | -0.15 | 0.05 | -2.07 | 0.44 |
| Other Operating Activities | -3.07 | 39.65 | 4.94 | -104.34 | 16.02 | 50.19 |
| Change in Accounts Receivable | -104.19 | -32.58 | -3.64 | -11.16 | -37.51 | -5.32 |
| Change in Inventory | -147.8 | -17.77 | -94.36 | -24.61 | -14.44 | -9.6 |
| Change in Accounts Payable | 261.01 | 78.46 | 31.04 | -8.33 | 9.17 | 4.3 |
| Change in Unearned Revenue | 40.62 | 24.7 | -3.23 | 13.54 | -3.26 | 4.85 |
| Change in Other Net Operating Assets | 0.83 | 75.01 | -61.49 | -27.28 | 171.44 | 41.61 |
| Operating Cash Flow | 1,877 | 1,647 | 931.64 | 692.4 | 834.12 | 656.46 |
| Operating Cash Flow Growth | 42.97% | 76.83% | 34.55% | -16.99% | 27.06% | - |
| Capital Expenditures | -204.76 | -226.3 | -152.66 | -75 | -75.51 | -85.47 |
| Divestitures | -3.51 | 33.13 | - | - | - | - |
| Sale (Purchase) of Intangibles | -2.13 | -2.13 | -0.59 | -0.13 | -0.83 | -0.18 |
| Investment in Securities | -250.65 | -379.47 | -718.65 | 1,447 | -686.94 | -506.98 |
| Other Investing Activities | 62.72 | 47.49 | 13.16 | 210.72 | 242.16 | 32.04 |
| Investing Cash Flow | -398.38 | -527.28 | -858.74 | 1,563 | -521.12 | -589.85 |
| Long-Term Debt Repaid | - | -1.05 | -0.19 | - | - | - |
| Net Debt Issued (Repaid) | -1.84 | -1.05 | -0.19 | - | - | - |
| Issuance of Common Stock | 1,555 | 56.4 | 583.51 | 0.06 | - | - |
| Repurchase of Common Stock | - | - | -6,236 | - | - | - |
| Dividends Paid | - | - | -367.46 | -2,550 | - | - |
| Other Financing Activities | -7.97 | -3.54 | -11.67 | -68.62 | -17.52 | -2.16 |
| Financing Cash Flow | 1,545 | 51.81 | -5,790 | 4,476 | -17.52 | -2.16 |
| Foreign Exchange Rate Adjustments | -17.17 | 1.09 | -55.18 | 3.98 | - | - |
| Net Cash Flow | 3,007 | 1,173 | -5,772 | 6,735 | 295.48 | 64.45 |
| Free Cash Flow | 1,673 | 1,421 | 778.97 | 617.4 | 758.62 | 570.98 |
| Free Cash Flow Growth | 64.61% | 82.44% | 26.17% | -18.61% | 32.86% | - |
| Free Cash Flow Margin | 37.51% | 40.33% | 32.95% | 39.77% | 63.72% | 59.68% |
| Free Cash Flow Per Share | 1.70 | 1.45 | 0.76 | 0.62 | 0.76 | 0.57 |
| Cash Income Tax Paid | 316.69 | 205.76 | 172.7 | 218.26 | 121.13 | 59.51 |
| Levered Free Cash Flow | 2,276 | 1,057 | -6,104 | 5,352 | 2,305 | - |
| Unlevered Free Cash Flow | 2,276 | 1,057 | -6,104 | 5,352 | 2,305 | - |
| Change in Net Working Capital | -1,149 | -223.25 | 6,705 | -4,817 | -1,856 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.